LentiCRISPRv2puro-Gnaq
(Plasmid
#170302)
-
PurposeA knock-out vector for the mouse Gnaq
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 170302 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneLentiCRISPRv2puro
-
Backbone manufacturerhttps://www.addgene.org/52961/
-
Vector typeLentiviral, CRISPR
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameA gRNA targeting the mouse Gnaq gene.
-
gRNA/shRNA sequenceGnaq
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
LentiCRISPRv2puro-Gnaq was a gift from Michiyuki Matsuda (Addgene plasmid # 170302 ; http://n2t.net/addgene:170302 ; RRID:Addgene_170302) -
For your References section:
Intravital imaging identifies the VEGF-TXA2 axis as a critical promoter of PGE2 secretion from tumor cells and immune evasion. Konishi Y, Ichise H, Watabe T, Oki C, Tsukiji S, Hamazaki Y, Murakawa Y, Takaori-Kondo A, Terai K, Matsuda M. Cancer Res. 2021 May 25. pii: 0008-5472.CAN-20-4245. doi: 10.1158/0008-5472.CAN-20-4245. 10.1158/0008-5472.CAN-20-4245 PubMed 34035084